It has been reported that FMT from PD patients can significantly worsen motor dysfunction in α-synuclein-overexpressing (ASO) mice compared to genotype-matched recipient mice receiving FMT from healthy human controls [17], but these findings only apply to the small portion of hereditary PD cases. The gene discussed is SNCA; the disease is Parkinson disease.